Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q2 Adjusted EBITDA Rises To SEK 11.3 Mln

July 13 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * XVIVO PRESENTS INTERIM REPORT JANUARY-JUNE 2022
    * Q2 NET SALES SEK 94.3 MILLION VERSUS SEK 59.3 MILLION YEAR
AGO
    * Q2 ADJUSTED EBITDA SEK 11.3 MILLION VERSUS SEK 8.4 MILLION
YEAR
AGO
    * Q2 NET PROFIT SEK 7.5 MILLION VERSUS NET LOSS SEK 8.9
MILLION
YEAR AGO

Source text for Eikon:  ID:nMFNc1D4qZ 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xvivo Perfusion AB

See all news